Hem Onc

The Division of Pediatric Hematology/Oncology evaluates, diagnoses and treats children with cancer and blood diseases.

We treat patients who range in age from infancy to young adulthood.

Our team of board-certified pediatric hematologists/oncologists provides comprehensive care for young patients with blood disorders and cancer.

Physicians in the Hematology/Oncology Division have expertise in sickle cell disease, hemophilia, bleeding disorders, strokes and other clotting problems, bone marrow failure syndromes, and abnormalities of red blood cells, white blood cells and platelets.

The Division is an active member of the University of Maryland’s Greenebaum Cancer Center, which is designated by the National Cancer Institute and Children’s Oncology Group. Participation allows pediatric patients with cancer to receive access to state-of-the art clinical trials being conducted nationally. In addition, the Division offers a new Cancer Survivor Program for survivors of pediatric cancers of any age to receive long-term follow up care.

Patient Conditions Treated

  • Acute and chronic leukemia

  • Solid cancers of childhood and adolescence

  • Brain tumors

  • Anemias

  • Bleeding and clotting disorders

  • Aplastic anemia

  • Granulocyte abnormalities

  • ITP and platelet abnormalities

  • Sickle cell disease 

  • Ehlers-Danlos syndrome

Comprehensive Evaluations for:

  • Blood disorders in children and adolescents

  • Malignancies in children and adolescents

  • Brain tumors in children and adolescents

Specialized Treatments

  • Chemotherapy

  • Coordination with surgeons and radiation oncologists

  • Proton Therapy

  • Stereotactic surgical techniques

  • Radioactive implants

  • Counseling and education

  • Cancer Survivorship

  • Hematology/genetics management

  • Inherited cancer syndromes clinic

  • Immunotherapy and COG

Research Activities

  • Neuroblastoma cell biology

  • Experimental therapy of neuroblastoma

  • Growth factor pathways in bone tumors

  • Clinical leukemia research

  • Clinical sickle cell research

Cancer Survivor Program

The Cancer Survivor Program at the University of Maryland offers evidence-based, individualized follow of pediatric cancer survivors to help them anticipate late effects of therapy and promote health. Survivors become eligible when they are off therapy for two years and are cancer-free. The Cancer Survivor Program is available to cancer survivors from the Baltimore area, state and larger community.


University of Maryland Medical Center 
22 S Greene St.
Fifth floor North Elevators, Room N5E16
Baltimore, MD 21201

University of Maryland at Upper Chesapeake Medical Center
510 Upper Chesapeake Drive
Physicians Pavilion II, Suite 509
Bel Air, MD 21014

Pediatric Specialty Practice
7556 Teague Road
Suite 420
Hanover, MD 21076

University of Maryland Pediatrics at Lutherville
1302 Bellona Ave.
Lutherville, MD 21093